Search filters

List of works by Gilles Salles

90Yttrium-ibritumomab tiuxetan consolidation of first remission in advanced-stage follicular non-Hodgkin lymphoma: updated results after a median follow-up of 7.3 years from the International, Randomized, Phase III First-LineIndolent trial.

scientific article published in April 2013

A 4-weekly course of rituximab is safe and improves tumor control for patients with minimal residual disease persisting 3 months after autologous hematopoietic stem-cell transplantation: results of a prospective multicenter phase II study in patient

scientific article published on 05 July 2012

A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts.

scientific article published on 20 February 2018

A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies

scientific article published on 5 November 2015

A phase 1 study of lirilumab (antibody against killer immunoglobulin-like receptor antibody KIR2D; IPH2102) in patients with solid tumors and hematologic malignancies.

scientific article

A restricted IGHV gene repertoire in splenic marginal zone lymphoma is associated with autoimmune disorders

scientific article published on 4 July 2014

A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy.

scientific article published on 17 April 2018

Absence of driver mutations in persistent polyclonal B-cell lymphocytosis with binucleated lymphocytes.

scientific article

Abstract LB-272: Genome-wide association study identifies multiple susceptibility loci for diffuse large B-cell lymphoma

Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymp

scientific article published on 13 June 2016

Administration of anticancer drugs: exposure in hospital nurses.

scientific article published on 5 March 2014

An open-label phase 1b study of obinutuzumab plus lenalidomide in relapsed/refractory follicular B-cell lymphoma

scientific article published on 01 August 2018

Analysis of VH genes in marginal zone lymphoma reveals marked heterogeneity between splenic and nodal tumors and suggests the existence of clonal selection.

scientific article published in April 2005

Appropriate time interval to repeat ambulatory blood pressure monitoring in patients with white-coat resistant hypertension.

scientific article published on 3 January 2012

Are we nearing an era of chemotherapy-free management of indolent lymphoma?

scientific article

Array-CGH predicts prognosis in plasma cell post-transplantation lymphoproliferative disorders

scientific article published on 17 October 2016

Authors' Reply

scientific article published on 01 March 2018

Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT.

scientific article

Autologous stem cell transplantation for primary mediastinal B-cell lymphoma: long-term outcome and role of post-transplant radiotherapy. A report of the European Society for Blood and Marrow Transplantation.

scientific article published on 20 February 2018

Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier

scientific article published on 01 March 2020

Baseline Metabolic Tumor Volume Predicts Outcome in High-Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies.

scientific article published on 22 August 2016

Baseline differential blood count and prognosis in CD20-positive post-transplant lymphoproliferative disorder in the prospective PTLD-1 trial

scientific article published on 15 April 2013

CD10 and ICOS expression by multiparametric flow cytometry in angioimmunoblastic T-cell lymphoma

scientific article (publication date: July 2011)

CD180 overexpression in follicular lymphoma is restricted to the lymph node compartment

scientific article published on 20 October 2015

CD1d-restricted peripheral T cell lymphoma in mice and humans

scientific article published on 11 April 2016

CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases

scientific article

CHOP and DHAP plus rituximab followed by autologous stem cell transplantation in mantle cell lymphoma: a phase 2 study from the Groupe d'Etude des Lymphomes de l'Adulte.

scientific article

Case report: Purulent transformation of granulocytic sarcoma: An unusual pattern of differentiation in acute promyelocytic leukemia.

scientific article published in February 2018

Cat-Scratch Disease: A Pitfall for Lymphoma Evaluation by FDG-PET/CT.

scientific article

Cause of Death in Follicular Lymphoma in the First Decade of the Rituximab Era: A Pooled Analysis of French and US Cohorts

scientific article published on 27 November 2018

Central nervous system involvement in chronic lymphocytic leukemia: uncommon manifestation with undefined therapeutic management.

scientific article

Chronic Borrelia burgdorferi infection triggers NKT lymphomagenesis

scientific article published on 02 November 2018

Chronic T cell receptor stimulation unmasks NK receptor signaling in peripheral T cell lymphomas via epigenetic reprogramming

scientific article published in 2021

Clinical characteristics and outcomes of relapsed follicular lymphoma after autologous stem cell transplantation in the rituximab era

scientific article published on 30 January 2020

Clinical outcome of patients with follicular lymphoma receiving chemoimmunotherapy in the PRIMA study is not affected by FCGR3A and FCGR2A polymorphisms.

scientific article published on 10 August 2012

Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis

scientific article published on 16 October 2006

Clinicopathologic features of Waldenstrom's macroglobulinemia and marginal zone lymphoma: are they distinct or the same entity?

scientific article

Combining gene expression profiling and machine learning to diagnose B-cell non-Hodgkin lymphoma

scientific article published on 22 May 2020

Comparative toxicities of 3 platinum-containing chemotherapy regimens in relapsed/refractory lymphoma patients.

scientific article

Comparison study for genotyping of a single-nucleotide polymorphism in the tumor necrosis factor promoter gene

scientific article published on 01 December 2002

Complete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma.

scientific article

Composite and sequential lymphoma between classical Hodgkin lymphoma and primary mediastinal lymphoma/diffuse large B-cell lymphoma, a clinico-pathological series of 25 cases

scientific article published on 06 February 2020

Conduct of epidemiologic studies in French cancer survivors: Methods, difficulties encountered and solutions provided. Lessons learned from the SIMONAL study on long-term toxicities after non-Hodgkin lymphoma treatment

scientific article published on 14 February 2017

Current and future management of follicular lymphoma.

scientific article published on 30 October 2012

Cytokine gene polymorphisms and progression-free survival in classical Hodgkin lymphoma by EBV status: results from two independent cohorts.

scientific article

Detailed characterization of 7q deletions by multicolor banding (mBAND) in marginal zone cell lymphoma

scientific article published on 01 June 2007

Development of model for analysing respective collections of intended hematopoietic stem cells and harvests of unintended mature cells in apheresis for autologous hematopoietic stem cell collection.

scientific article published on 2 January 2014

Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical Trials.

scientific article published on 19 April 2018

Distribution of the cytogenetic abnormality +i(3)(q10) in persistent polyclonal B‐cell lymphocytosis: a FICTION study in three cases ⬇️

scientific article published on 01 December 1997

Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial.

scientific article published on 9 April 2013

EZH2 inhibition by tazemetostat: mechanisms of action, safety and efficacy in relapsed/refractory follicular lymphoma

scientific article published in 2021

Early event status informs subsequent outcome in newly diagnosed follicular lymphoma.

scientific article published on 27 July 2016

Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 study

scientific article published on 15 December 2016

Elderly Patients (Age 70 Years or Older) With Secondary Acute Myeloid Leukemia or Acute Myeloid Leukemia Developed Concurrently to Another Malignant Disease.

scientific article published on 2 March 2018

Elevated IL-10 plasma levels correlate with poor prognosis in diffuse large B-cell lymphoma

scientific article published on 01 March 2006

Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy.

scientific article published on 18 February 2014

Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma

scientific article published on 27 July 2017

Extracorporeal cytokine adsorption for treating severe refractory cytokine release syndrome (CRS)

scientific article published on 10 April 2020

FCGR3A/2A polymorphisms and diffuse large B-cell lymphoma outcome treated with immunochemotherapy: a meta-analysis on 1134 patients from two prospective cohorts

scientific article published on 10 June 2016

FDG PET/CT Findings in Abdominal Fat Necrosis After Treatment for Lymphoma

scientific article published on 28 January 2016

FLT3-TKD Mutations Associated With NPM1 Mutations Define a Favorable-risk Group in Patients With Acute Myeloid Leukemia

scientific article published on 13 June 2018

Factors associated with carotid intima-media thickness and carotid plaques in type 2 diabetic patients

scientific article published on 01 May 2012

Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy.

scientific article published on 29 March 2017

First immunochemotherapy outcomes in elderly patients with CLL: a retrospective analysis

scientific article published on 26 February 2013

From genetics to the clinic: a translational perspective on follicular lymphoma.

scientific article published on 9 February 2018

Gene expression profiling of gray zone lymphoma

scientific article published on 01 June 2020

Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes

scientific article published on 13 August 2019

Genetically Determined Height and Risk of Non-hodgkin Lymphoma

scientific article published on 01 January 2019

Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes

scientific article

Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region

scientific article published in October 2014

Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma

scientific article

Gray-zone Lymphoma Between cHL and Large B-Cell Lymphoma: A Histopathologic Series From the LYSA

scientific article published on 01 March 2019

HLA class I and II diversity contributes to the etiologic heterogeneity of non-Hodgkin lymphoma subtypes.

scientific article

Hairy cell leukaemia-variant and splenic red pulp lymphoma: a single entity?

scientific article published on 11 March 2010

Heterogeneity of acute lymphoblastic leukemia in HIV-seropositive patients ⬇️

scientific article published on May 1, 1994

High DNA methyltransferase DNMT3B levels: a poor prognostic marker in acute myeloid leukemia

scientific article

High total metabolic tumor volume at baseline predicts survival independent of response to therapy

scientific article published on 01 April 2020

High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma

scientific article published on 28 May 2015

Histologic transformation in follicular lymphoma ⬇️

scientific article published on August 1, 1998

Human germinal center transcriptional programs are de-synchronized in B cell lymphoma

scientific article published on 13 August 2018

Human leukocyte antigens class II and tumor necrosis factor genetic polymorphisms are independent predictors of non-Hodgkin lymphoma outcome

scientific article published in October 2002

Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study.

scientific article

Identification of MUM1 as a prognostic immunohistochemical marker in follicular lymphoma using computerized image analysis

scientific article published on 17 July 2014

Identification of an alternative CD20 transcript variant in B-cell malignancies coding for a novel protein associated to rituximab resistance

scientific article

Immunoarchitectural patterns in splenic marginal zone lymphoma: correlations with chromosomal aberrations, IGHV mutations, and survival. A study of 76 cases

scientific article published in May 2013

Immunoglobulin heavy chain/light chain pair measurement is associated with survival in diffuse large B-cell lymphoma

scientific article published on 18 February 2013

Impact of Expert Pathologic Review of Lymphoma Diagnosis: Study of Patients From the French Lymphopath Network

scientific article

Impact of [(18)F]fluorodeoxyglucose positron emission tomography response evaluation in patients with high-tumor burden follicular lymphoma treated with immunochemotherapy: a prospective study from the Groupe d'Etudes des Lymphomes de l'Adulte and G

scientific article published on 29 October 2012

Impact of rituximab on stem cell mobilization following ACVBP regimen in poor-risk patients with diffuse large B-cell lymphoma: results from a large cohort of patients.

scientific article published on 7 May 2012

Impact of the use of autologous stem cell transplantation at first relapse both in naive and previously rituximab exposed follicular lymphoma patients treated in the GELA/GOELAMS FL2000 study.

scientific article

Impact of using leader primers for IGHV mutational status assessment in chronic lymphocytic leukemia

scientific article published on 29 January 2020

In non-follicular lymphoproliferative disorders, IGH/BCL2-fusion is not restricted to chronic lymphocytic leukaemia

scientific article published on 12 June 2012

Indications for hematopoietic stem cell transplantation in patients with follicular lymphoma: a consensus project of the EBMT-Lymphoma Working Party

scientific article published on July 2013

Intensive Salvage Therapy With High-Dose Chemotherapy for Patients With Advanced Hodgkin’s Disease in Relapse or Failure After Initial Chemotherapy: Results of the Groupe d’Études des Lymphomes de l’Adulte H89 Trial ⬇️

scientific article published on January 15, 2002

Is There a Role for Bortezomib Combinations in the Management of Patients With Follicular Lymphoma? ⬇️

scientific article published on September 1, 2011

Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.

scientific article published on 20 April 2017

Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study

scientific article published on 01 September 2018

Lipid Trait Variants and the Risk of Non-Hodgkin Lymphoma Subtypes: A Mendelian Randomization Study

scientific article published on 27 February 2020

Long-term fatigue in survivors of non-Hodgkin lymphoma: The Lymphoma Study Association SIMONAL cross-sectional study

article

Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma.

scientific article published on 03 May 2013

Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment.

scientific article published on 6 May 2014

Long-term follow-up of patients with CLL treated with the selective Bruton's tyrosine kinase inhibitor ONO/GS-4059.

scientific article published on 4 April 2017

Long-term follow-up of patients with mantle cell lymphoma (MCL) treated with the selective Bruton's tyrosine kinase inhibitor tirabrutinib (GS/ONO-4059)

scientific article published on 11 December 2019

Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study

scientific article published on 24 February 2018

Low Serum Vitamin D Levels Are Associated With Inferior Survival in Follicular Lymphoma: A Prospective Evaluation in SWOG and LYSA Studies

scientific article published on 30 March 2015

Lupus-related single nucleotide polymorphisms and risk of diffuse large B-cell lymphoma

scientific article

Lymphoma occurring in patients over 90 years of age: characteristics, outcomes, and prognostic factors. A retrospective analysis of 234 cases from the LYSA.

scientific article published on 22 August 2013

MALT lymphomas: pathogenesis can drive treatment.

scientific article

Maintenance therapy in follicular lymphoma ⬇️

scientific article published on September 1, 2011

Management of relapsed or refractory follicular lymphoma patients in daily practice - a French non-interventional study

scientific article published on 28 February 2018

Mediastinal gray zone lymphoma: clinico-pathological characteristics and outcomes of 99 patients from the Lymphoma Study Association

scientific article published on 06 October 2016

Metagenomic Next-Generation Sequencing Reveals Individual Composition and Dynamics of Anelloviruses during Autologous Stem Cell Transplant Recipient Management

article

MicroRNA expression profile in splenic marginal zone lymphoma

scientific article published on 09 September 2011

Monitoring NK cell activity in patients with hematological malignancies.

scientific article published on 12 September 2013

Multicenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkin's lymphoma.

scientific article

New Agents to Treat Chronic Lymphocytic Leukemia.

scientific article published in June 2016

Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

scientific article published on 13 August 2014

Nodal marginal zone B-cell lymphoma: a diagnostic and therapeutic dilemma

scientific article published on January 2012

Obinutuzumab (GA101) in patients with relapsed/refractory indolent non-Hodgkin lymphoma: results from the phase II GAUGUIN study.

scientific article published on 8 July 2013

Obinutuzumab (GA101) monotherapy in relapsed/refractory diffuse large b-cell lymphoma or mantle-cell lymphoma: results from the phase II GAUGUIN study.

scientific article

Obinutuzumab (GA101) plus CHOP or FC in relapsed/refractory follicular lymphoma: results of the GAUDI study (BO21000).

scientific article published on 10 July 2013

Obinutuzumab for chronic lymphocytic leukemia

scientific article

Obinutuzumab plus Lenalidomide (GALEN) for the treatment of relapse/refractory aggressive lymphoma: a phase II LYSA study

scientific article published on 05 October 2018

Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial

scientific article

One-Year Follow-Up of Natural Killer Cell Activity in Multiple Myeloma Patients Treated With Adjuvant Lenalidomide Therapy.

scientific article

Overall Survival Benefit in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma Who Received Obinutuzumab Plus Bendamustine Induction and Obinutuzumab Maintenance in the GADOLIN Study

scientific article published on 27 March 2018

PET-CT and diagnostic CT: the synergy of metabolic and morphological data in onco-haematology

scientific article

PET/CT assessment in follicular lymphoma using standardized criteria: central review in the PRIMA study

scientific article published on 17 January 2014

PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma

scientific article

Peripheral blood involvement in patients with follicular lymphoma: a rare disease manifestation associated with poor prognosis

scientific article

Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphoma

scientific article published on 22 October 2015

Pharmacology, immunogenicity, and efficacy of a novel pegylated recombinant Erwinia chrysanthemi-derived L-asparaginase

scientific article published on 15 May 2014

Phase 1 study results of the type II glycoengineered humanized anti-CD20 monoclonal antibody obinutuzumab (GA101) in B-cell lymphoma patients.

scientific article

Phase 1b study of lenalidomide in combination with rituximab-CHOP (R2-CHOP) in patients with B-cell lymphoma

scientific article published on 26 June 2012

Phase 2 Study of Daratumumab in Relapsed/Refractory Mantle-Cell Lymphoma, Diffuse Large B-Cell Lymphoma, and Follicular Lymphoma

scientific article published on 02 January 2019

Plasma TNF-alpha and IL-10 level-based prognostic model predicts outcome of patients with diffuse large B-Cell lymphoma in different risk groups defined by the International Prognostic Index

scientific article published on 27 February 2010

Predictive gene-expression score for follicular lymphoma - Authors' reply

scientific article published on 01 June 2018

Predictors of prescription errors involving anticancer chemotherapy agents

scientific article published on 28 January 2012

Pregnancy and multiple myeloma are not antinomic.

scientific article

Pretreatment levels of vascular endothelial growth factor in plasma predict a complete remission rate and time to relapse or progression in patients with diffuse large B-cell lymphoma

scientific article published on 3 January 2013

Prevalence and pattern of antinuclear autoantibodies in 347 patients with non‐Hodgkin's lymphoma ⬇️

scientific article published on October 1, 2003

Prognostic factors in resistant hypertension: implications for cardiovascular risk stratification and therapeutic management.

scientific article published on June 2012

Prognostic model for high tumor burden follicular lymphoma integrating baseline and end induction PET: a LYSA/FIL study.

scientific article published on 20 March 2018

Rapamycin safeguards lymphocytes from DNA damage accumulation in vivo.

scientific article

Recurrent cerebral venous thrombosis revealing paraneoplastic angiitis in Hodgkin's lymphoma

scientific article published on 07 May 2008

Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma

scientific article published on 16 June 2016

Refractory diffuse large B-cell lymphoma after first-line immuno-CT: Treatment options and outcomes

scientific article published on 02 May 2018

Relevance of a scoring system including CD11c expression in the identification of splenic diffuse red pulp small B‐cell lymphoma (SRPL) ⬇️

scientific article published on March 1, 2011

Reply to H.J.A. Adams et al and E. Laffon et al

scientific article published on 28 December 2016

Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial.

scientific article published on 19 December 2016

Risk Factors and Outcomes for Patients With Follicular Lymphoma Who Had Histologic Transformation After Response to First-Line Immunochemotherapy in the PRIMA Trial.

scientific article published on 13 June 2016

Rituximab Maintenance for the Treatment of Patients With Follicular Lymphoma: An Updated Systematic Review and Meta-analysis of Randomized Trials ⬇️

scientific article published on October 21, 2011

Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma.

scientific article published in September 2017

Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis

scientific article published on 04 July 2018

Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study Association report

scientific article published in March 2017

Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience

scientific article published on 5 October 2017

Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-up

scientific article published on 10 July 2012

Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial.

scientific article

Rituximab maintenance obviates the poor prognosis associated with circulating lymphoma cells in patients with follicular lymphoma

scientific article published on 01 April 2014

Rituximab maintenance therapy after autologous stem-cell transplantation in patients with relapsed CD20(+) diffuse large B-cell lymphoma: final analysis of the collaborative trial in relapsed aggressive lymphoma

scientific article published on 22 October 2012

Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma

scientific article published on 01 September 2018

Rituximab plus gemcitabine and oxaliplatin in patients with refractory/relapsed diffuse large B-cell lymphoma who are not candidates for high-dose therapy. A phase II Lymphoma Study Association trial

scientific article published on 10 June 2013

Role of up-front autologous stem cell transplantation in peripheral T-cell lymphoma for patients in response after induction: An analysis of patients from LYSA centers

scientific article

Sequential combination of high dose methotrexate and L-asparaginase followed by allogeneic transplant: a first-line strategy for CD4+/CD56+ hematodermic neoplasm

scientific article published on 16 March 2012

Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.

scientific article published on 13 December 2011

Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphoma

scientific article published on 14 February 2020

Single-agent ibrutinib in RESONATE-2™ and RESONATE™ versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia

scientific article published on 19 November 2019

Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis

scientific article

Splenic diffuse red pulp lymphoma has a distinct pattern of somatic mutations amongst B-cell malignancies.

scientific article published on 27 June 2016

Splenic diffuse red pulp small-B cell lymphoma: toward the emergence of a new lymphoma entity

scientific article published on April 2012

Splenic marginal zone lymphoma: current knowledge and future directions.

scientific article published on February 2012

Splenic marginal-zone lymphoma: a distinct clinical and pathological entity

scientific article

Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity?

scientific article published on 27 November 2007

Successful pregnancies in patients with BCR-ABL-positive leukemias treated with interferon-alpha therapy during the tyrosine kinase inhibitors era

scientific article published on 08 October 2018

Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA.

scientific article

Symptoms and toxicity of rituximab maintenance relative to observation following immunochemotherapy in patients with follicular lymphoma

scientific article

Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA

scientific article

Targeting netrin-1/DCC interaction in diffuse large B-cell and mantle cell lymphomas

scientific article published on 31 January 2016

The 2016 revision of the World Health Organization classification of lymphoid neoplasms

scientific article published on 15 March 2016

The Prognostic Impact of CD163-Positive Macrophages in Follicular Lymphoma: A Study from the BC Cancer Agency and the Lymphoma Study Association.

scientific article

The ibrutinib B-cell proliferation inhibition is potentiated in vitro by dexamethasone: Application to chronic lymphocytic leukemia.

scientific article published on 10 May 2016

The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium

scientific article published on 07 February 2014

Through the Glass Ceiling.

scientific article published on 25 January 2018

Toll-like receptor expression and function differ between splenic marginal zone B cell lymphoma and splenic diffuse red pulp B cell lymphoma.

scientific article published on 4 May 2018

Treatment approaches to asymptomatic follicular lymphoma

scientific article published on December 2013

Treatment patterns and comparative effectiveness in elderly acute myeloid leukemia patients (age 70 years or older): the Lyon-university hospital experience

scientific article

Unclassifiable Isolated Monoclonal Lymphocytosis: Comprehensive Description of a Retrospective Cohort

scientific article published on 04 October 2019

Use of Commercial anti-CD19 CAR T Cell Therapy for Patients with Relapsed/Refractory Aggressive B Cell Lymphoma in a European center

scientific article published on 03 August 2020

Usefulness of CD200 in the differential diagnosis of SDRPL, SMZL, and HCL

scientific article published on 16 April 2018

Usefulness of the vibration perception thresholds measurement as a diagnostic method for diabetic peripheral neuropathy: Results from the Rio de Janeiro type 2 diabetes cohort study

scientific article published on 18 June 2018

Validation of the prognostic value of the knowledge bank approach to determine AML prognosis in real life

scientific article published on 04 June 2018

What Does This Mutation Mean? The Tools and Pitfalls of Variant Interpretation in Lymphoid Malignancies.

scientific article published on 20 April 2018

What is the best first-line treatment strategy for patients with indolent lymphomas?

scientific article published on 01 January 2012

[The role of HLA DRB1 genetic polymorphisms in non-Hodgkin's lymphomas]

scientific article published on 01 January 2005

[The role of genetic polymorphisms within tumor necrosis factor promoter gene in non-Hodgkin's lymphomas]

scientific article published on 01 January 2005

t(14;18) Translocation: A Predictive Blood Biomarker for Follicular Lymphoma

µ-Calpain conversion of antiapoptotic Bfl-1 (BCL2A1) into a prodeath factor reveals two distinct alpha-helices inducing mitochondria-mediated apoptosis.

scientific article

Paulina is supported by:

About Paulina

Help